Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
ERJ Open Research|December 2, 2021
A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertensionGudula J A M Boon, Wilbert B van den Hout, Stefano Barco, et al.
Nuclear Medicine and Biology|June 6, 2022
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5Lonneke Rotteveel, Kondababu Kurakula, Esther J M Kooijman, et al.
Circulation. Heart Failure|July 3, 2016
Right Ventricular Myocardial Stiffness in Experimental Pulmonary Arterial Hypertension: Relative Contribution of Fibrosis and Myofibril StiffnessSilvia Rain, Stine Andersen, Aref Najafi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 4, 2023
Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19Nadia Baalbaki, Erik Duijvelaar, Medhat M Said, et al.
Journal of the American Heart Association|February 15, 2023
Right Ventricular Function During Exercise After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary HypertensionNatalia J Braams, Azar Kianzad, Lilian J Meijboom, et al.
Pulmonary Circulation|April 19, 2019
Pressure overload induced right ventricular remodeling is not attenuated by the anti-fibrotic agent pirfenidoneStine Andersen, Julie Birkmose Axelsen, Steffen Ringgaard, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 19, 2016
Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertensionEmmy Manders, Peter I Bonta, Jaap J Kloek, et al.
Angiogenesis|August 20, 2020
Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cellsRobert Szulcek, Gonzalo Sanchez-Duffhues, Nina Rol, et al.
Chest|July 26, 2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersChristian Gerges, Antoine Beurnier, Xavier Jaïs, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib studyImke H Bartelink, Pierre M Bet, Nicolas Widmer, et al.
Pageof 19